Information Provided By:
Fly News Breaks for July 15, 2016
ACHC
Jul 15, 2016 | 07:29 EDT
Jefferies analyst Brian Tanquilut believes Acadia Healthcare investors overreacted to the U.K.'s Competition & Markets Authority expressing anti-competitive concerns in 20 of the company's U.K. markets due to its Priory acquisition. Acadia management is committed to pursuing a compromise that is acceptable to the agency within the next five that should lead to final approval of the Priory deal by July 28, Tanquilut tells investors in a research note. He views yesterday's pullback in Acadia shares as a buying opportunity. The analyst keeps a Buy rating on the name with an $85 price target.